Phase II Application

These two-year awards assist innovations within the later stages of proof-of-concept and development, equivalent to Technology Readiness Levels 4 – 5.

In the life sciences, the invention has been validated in vitro with in vivo testing underway or complete. In all other fields, technologies are approaching near final commercial performance.

Step 1 of 6 - General Information

General Information
Principal Investigator*
First Last
PI Title*
Email Address*
Office Phone*
Mobile Phone
Department*
College*
Department
College
Project Title*
Related Inventions*
Provide a list of all Northeastern inventions related to this project (INV-# and Titles)
Technology Readiness Level Before Project*
Please refer to the chart below to best judge the current Technology Readiness Level of your technology
Comments*
Projected Technology Readiness Level After Project*
Please refer to the chart below to best estimate the Technology Readiness Level of your technology AFTER project completion
Comments*

Technology Readiness Level Chart

Technology Readiness Level	Life Sciences	Physical Sciences and Software
Level 1	Basic observations and new hypothesis reported	Basic observations and new hypothesis reported
Level 2	Novel paradigm/composition of matter/method formulated; corroborating preliminary results obtained	Technology concept and/or application formulated; no experimental proof or detailed analysis yet supports the conjecture
Level 3	Analytical or experimental proof-of-concept (POC) established; In-vitro demonstration of consistent results to validate hypothesis	R&D is initiated: analytical studies set the technology into an appropriate context and “proof-of-concept” laboratory-based studies physically validate that the analytical predictions are correct
Level 4	Proof-of-concept established in complex in-vitro settings along with demonstrated competitive added value	Basic technological elements integrated to establish that the “pieces” will work together to achieve concept-enabling levels of performance for a component and/or breadboard
Level 5	Invention validated in a relevant environment; In-vivo POC established in small animals.	Component and/or breadboard validated in a relevant environment
Level 6	Invention validated in a relevant environment; In-vivo POC established in other species (canine, feline, etc.)	System/subsystem model or prototype near the desired configuration in terms of performance, weight, and volume tested in a relevant environment
Level 7	Invention demonstrated in an operational environment; In-vivo POC established in non-human primates	System prototype demonstrated in an operational environment
Level 8	Invention completed and qualified through test and demonstration; POC established in humans / Phase I clinical trials	Actual system completed and qualified through test and demonstration
Level 9	Invention proven successful in Phase II and III clinical trials and in commercial settings	Actual system proven through successful mission operations

Brief Project Summary (200 words max)*
How will the proposed development project accelerate the impact and commercialization development of your technology?
Budget (not to exceed $100,000)*
Drop files here or

Accepted file types: pdf, xlsx.
Budget Narrative (250 words max)
Please note: Phase II awards are $100,000. If you believe this project is an exceptional case warranting a larger grant, in your budget narrative explain how the additional funds – up to $50,000 – could boost the invention's commercial status. We will ask for additional information as necessary.
Project Timeline (not to exceed two years from time of funding)*
Drop files here or

Accepted file types: pdf, xlsx.
Timeline Narrative (250 words max)
Please note: Phase II awards are for two years. If you believe this project is an exceptional case warranting a longer duration, explain in your timeline narrative how the additional time – up to one year – will boost the invention's commercial status. We will ask for additional information as necessary.

Save and Continue Later

Team
Provide background on the lab(s). How does the experience of the team enhance the likelihood of success?*
Researcher

Provide a list of all project team members, titles and biosketches. Biosketches should include the following: education, professional experience, up to 3 relevant publications, up to 3 most closely related products, up to 3 related activities (PDF only; 2 pages max each biosketch).
Researcher 1*
First Last
Researcher 1 Title*
Researcher 1 Biosketch (max 2 pages)*
Drop files here or

Accepted file types: pdf.
Number of Additional Researchers
- 0
- 1
- 2
- 3
- 4
Researcher 2
First Last
Researcher 2 Title
Researcher 2 Biosketch (max 2 pages)
Drop files here or

Accepted file types: pdf.
Researcher 3
First Last
Researcher 3 Title
Researcher 3 Biosketch (max 2 pages)
Drop files here or

Accepted file types: pdf.
Researcher 4
First Last
Researcher 4 Title
Researcher 4 Biosketch (max 2 pages)
Drop files here or

Accepted file types: pdf.
Researcher 5
First Last
Researcher 5 Title
Researcher 5 Biosketch (max 2 pages)
Drop files here or

Accepted file types: pdf.
Mentor (at least one required)*
Please list your business mentor(s). If you do not have a business mentor, contact GapFund360@northeastern.edu

Save and Continue Later

Technology Background
Briefly describe the technology (400 words max)*
■ What problem are you trying to solve?
■ How is the problem currently being addressed?
■ What aspects are novel and/or disruptive compared to the current state of the art?
■ What are the key differentiators of this technology?
■ What is the societal value of this technology?
Have you received any government / sponsored research funding for this technology?*
■ Who funded the research?
■ How much was the funding?
■ What are/were the start & end dates for this funding?
What approvals (IRB, Animal Subjects, regulatory, other) will be necessary before this project begins? (if applicable)

Save and Continue Later

Deliverables
Describe the key deliverables (milestones) of this Gap Fund Phase II project (up to 5 deliverables, 50 words per deliverable)
Key Deliverable 1*
Key Deliverable 2
Key Deliverable 3
Key Deliverable 4
Key Deliverable 5
Key Deliverable 6
Key Deliverable 7
Key Deliverable 8
Key Deliverable 9
Key Deliverable 10

Save and Continue Later

Commercialization Outlook
Describe the market for this technology (100 words max)*
Provide examples of competing products/technologies (100 words max)*
Is there existing corporate interest in this innovation? If so, please provide details. (100 words max)*
What commercialization path do you envision for the technology? (Please describe your ONE most likely scenario; 200 words max.)*
Scenario 1: Lab members are possibly interested in commercializing this technology, for example, via spin-out. (Note: This is not a requirement for GapFund360 grants). Please describe your preliminary spin-out plans and timing.

or

Scenario 2: We prefer that the CRI license any resulting technology. Please provide five companies that you believe will be interested in licensing it, your reasoning, and any contacts you can provide.

Save and Continue Later

Documents
Ensure you have uploaded all documents before submitting your application.
Letters of Support (Minimum 2, Maximum 4)*
Drop files here or

Accepted file types: pdf.
Optional Supplemental Materials
Drop files here or

Accepted file types: pdf.
Agreement*
I agree to the GapFund360 Terms & Guidelines.
Comments
This field is for validation purposes and should be left unchanged.

Save and Continue Later

Phase II Application

These two-year awards assist innovations within the later stages of proof-of-concept and development, equivalent to Technology Readiness Levels 4 – 5.

In the life sciences, the invention has been validated in vitro with in vivo testing underway or complete. In all other fields, technologies are approaching near final commercial performance.

Step 1 of 6 - General Information

General Information

Technology Readiness Level Chart

Team

Researcher

Technology Background

Deliverables

Commercialization Outlook

Documents